QuickView for frdA;jsessionid=2E2EDE944854D68EAC8414EC89E6AD75;jsessionid=4DF4DABE4C3773B2684541A0B4DC5DED;jsessionid=F41D372FBB365C5AD8666F2B95DF93EB (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Myeloid cells of peripheral blood
Fetal liver
Microglial cell
Liver
Hematopoietic stem cell of bone marrow

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Spinocerebellar ataxia
Encephalomyelopathy
Helicobacter pylori gastrointestinal tract infection
Barrett's esophagus
Age AND/OR growth finding

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

Hydroflumethiazide
Vaccines, DNA
flumequine
Propidium
Vaccines

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

Mir9-3
Map3k1
MUTYH
KCNK1
BAG6

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich'…
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia.
Frataxin deficiency shifts metabolism to promote reactive microglia via glucose catabolism.
A modified mouse model of Friedreich's ataxia with conditional Fxn allele homozygosity delays onset …
Molecular approaches for the treatment and prevention of Friedreich's ataxia.

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for frdA;jsessionid=2E2EDE944854D68EAC8414EC89E6AD75;jsessionid=4DF4DABE4C3773B2684541A0B4DC5DED;jsessionid=F41D372FBB365C5AD8666F2B95DF93EB

Explore Clinical Trials Results